Avista (AVA) At $49.77 Forms Top; Cross Country Healthcare Has 2.02 Sentiment

Avista Corporation (AVA) formed multiple top with $52.26 target or 5.00% above today’s $49.77 share price. Avista Corporation (AVA) has $3.21 billion valuation. The stock decreased 1.29% or $0.65 during the last trading session, reaching $49.77. About 560,775 shares traded or 32.26% up from the average. Avista Corporation (NYSE:AVA) has risen 5.40% since February 6, 2017 and is uptrending. It has underperformed by 11.30% the S&P500.

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company has market cap of $470.60 million. The firm operates through three divisions: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. It has a 263.27 P/E ratio. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch local nurses and allied staffing; and short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments.

Analysts await Avista Corporation (NYSE:AVA) to report earnings on February, 20. They expect $0.54 earnings per share, down 12.90% or $0.08 from last year’s $0.62 per share. AVA’s profit will be $34.78M for 23.04 P/E if the $0.54 EPS becomes a reality. After $0.14 actual earnings per share reported by Avista Corporation for the previous quarter, Wall Street now forecasts 285.71% EPS growth.

Among 5 analysts covering Avista (NYSE:AVA), 0 have Buy rating, 1 Sell and 4 Hold. Therefore 0 are positive. Avista had 7 analyst reports since March 18, 2016 according to SRatingsIntel. UBS downgraded the stock to “Sell” rating in Friday, March 18 report. The company was maintained on Thursday, September 22 by Williams Capital Group. BMO Capital Markets maintained Avista Corporation (NYSE:AVA) on Thursday, July 20 with “Hold” rating. Williams Capital Group maintained the shares of AVA in report on Thursday, February 23 with “Hold” rating. The company was maintained on Wednesday, October 18 by KeyBanc Capital Markets. As per Thursday, March 31, the company rating was initiated by Mizuho. As per Thursday, February 23, the company rating was maintained by Mizuho.

Since December 13, 2017, it had 0 insider purchases, and 1 insider sale for $77,370 activity. Shares for $77,370 were sold by Thackston Jason R on Wednesday, December 13.

Investors sentiment decreased to 0.75 in 2017 Q3. Its down 0.45, from 1.2 in 2017Q2. It turned negative, as 50 investors sold Avista Corporation shares while 71 reduced holdings. 43 funds opened positions while 48 raised stakes. 46.81 million shares or 5.21% more from 44.49 million shares in 2017Q2 were reported. Jpmorgan Chase & Co owns 0.02% invested in Avista Corporation (NYSE:AVA) for 1.61 million shares. Lsv Asset Mgmt invested 0.05% of its portfolio in Avista Corporation (NYSE:AVA). Mark Sheptoff Planning Ltd has 5,500 shares. Manufacturers Life The has 50,464 shares for 0% of their portfolio. Parkside Bank & Trust owns 44 shares or 0% of their US portfolio. Chatham Cap Group Incorporated stated it has 25,705 shares or 0.38% of all its holdings. James Investment Rech has 0.01% invested in Avista Corporation (NYSE:AVA). Strs Ohio has invested 0% in Avista Corporation (NYSE:AVA). Aqr Mngmt Limited reported 116,483 shares. Moreover, M&R Capital Management Incorporated has 0.02% invested in Avista Corporation (NYSE:AVA) for 2,000 shares. Dimensional Fund Advsrs Ltd Partnership has invested 0.03% in Avista Corporation (NYSE:AVA). Assetmark reported 0% in Avista Corporation (NYSE:AVA). Texas Yale Capital invested 0.06% in Avista Corporation (NYSE:AVA). State Board Of Administration Of Florida Retirement Systems invested 0.01% in Avista Corporation (NYSE:AVA). Royal National Bank Of Canada stated it has 0% of its portfolio in Avista Corporation (NYSE:AVA).

Ratings analysis reveals 50% of Cross Country’s analysts are positive. Out of 2 Wall Street analysts rating Cross Country, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. CCRN was included in 2 notes of analysts from January 20, 2017. The company was downgraded on Tuesday, January 24 by Avondale. Benchmark initiated Cross Country Healthcare, Inc. (NASDAQ:CCRN) on Friday, January 20 with “Buy” rating.

Analysts await Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report earnings on March, 7. They expect $0.19 earnings per share, down 5.00% or $0.01 from last year’s $0.2 per share. CCRN’s profit will be $6.93M for 16.97 P/E if the $0.19 EPS becomes a reality. After $0.23 actual earnings per share reported by Cross Country Healthcare, Inc. for the previous quarter, Wall Street now forecasts -17.39% negative EPS growth.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $596,989 activity.

Hawk Ridge Capital Management Lp holds 2.32% of its portfolio in Cross Country Healthcare, Inc. for 434,082 shares. Alphaone Investment Services Llc owns 454,788 shares or 1.72% of their US portfolio. Moreover, Skyline Asset Management Lp has 1.49% invested in the company for 1.32 million shares. The California-based Engaged Capital Llc has invested 0.99% in the stock. Eagle Boston Investment Management Inc, a Massachusetts-based fund reported 660,195 shares.